Red Yeast Rice
Monascus purpureus · Monacolin K · Xuezhikang
Snapshot
| Indications | Contraindications |
|---|---|
Red yeast rice is rice fermented with Monascus mold, which can enrich it with monacolin K, structurally identical to the medicine lovastatin and acting like a statin on cholesterol synthesis6. Use extends to coronary events after myocardial infarction and to blood glucose and pressure, where trials are fewer6.
Meta-analyses of randomized trials found lower total and LDL cholesterol than control2, 3. Safety readings differ: a trial meta-analysis found no excess muscle disorders, while a 2018 European Food Safety Authority opinion found no guaranteed safe monacolin level6. A 2025 laboratory analysis of selected food supplements found monacolin K content did not match the manufacturer's declaration in any product tested9. Products are mostly capsules and tablets; see Form comparison.
Because monacolin K is lovastatin, muscle, liver, and kidney effects and drug interactions follow statin patterns6. Contamination is a separate hazard: citrinin can damage the kidneys6, and Japanese cases since 2024 involved kidney injury with Fanconi syndrome10.
Last updated October 16, 2026. Read how we make monographs.
In the full monograph
89 sources, 72 studies
- When to useThe situations practitioners use it for, each with the reason and the study behind it.
- SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
- InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
- Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
- How it worksWhat it is and how it works in the body, in plain terms.
- Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
- Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
- Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.
Sources
- 1Red Yeast Rice for Hypercholesterolemia.pubmed.ncbi.nlm.nih.govCicero, Fogacci, Banach · Methodist DeBakey cardiovascular journal · 2019 · Pubmed
- 2Impact of red yeast rice supplementation on lipid profile: a systematic review and meta-analysis of randomized-controlled trials.pubmed.ncbi.nlm.nih.govRahmani, Melekoglu, Tavakoli et al. · Expert review of clinical pharmacology · 2023 · Pubmed
- 3Safety and Efficacy of the Consumption of the Nutraceutical "Red Yeast Rice Extract" for the Reduction of Hypercholesterolemia in Humans: A Systematic Review and Meta-Analysis.pubmed.ncbi.nlm.nih.govTrogkanis, Karalexi, Sergentanis et al. · Nutrients · 2024 · Pubmed
- 4Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis.pubmed.ncbi.nlm.nih.govGerards, Terlou, Yu et al. · Atherosclerosis · 2015 · Pubmed
- 5Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).pubmed.ncbi.nlm.nih.govLi, Lu, Kou et al. · Annals of medicine · 2010 · Pubmed
- 6NCCIHnccih.nih.govNational Center for Complementary and Integrative Health
- 7US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm
- 8MSKCCmskcc.orgMemorial Sloan Kettering — About Herbs, Botanicals & Other Products
- 9Determination of Monacolin K and Citrinin in the Presence of Other Active Ingredients Found in Selected Food Supplements by HPLC-DAD.pubmed.ncbi.nlm.nih.govHubicka, Żuromska-Witek, Szlósarczyk et al. · Molecules (Basel, Switzerland) · 2025 · Pubmed
- 10Acute Kidney Injury and Fanconi Syndrome Caused by a Red Yeast Rice Supplement.pubmed.ncbi.nlm.nih.govDoi, Shimizu, Morimoto et al. · Internal medicine (Tokyo, Japan) · 2025 · Pubmed